| Long name: |
PPARD Polyclonal Antibody |
| Antigen: |
PPARD |
| Synonim names: |
NR1C2, NUC1, NUCI, NUCII, PPARB, FAAR |
| Other names: |
NUC1, NUCI, Nuclear hormone receptor 1, Nuclear receptor subfamily 1 group C member 2, PPAR-beta, PPAR-beta, PPAR-delta, Peroxisome proliferator-activated receptor beta, Peroxisome proliferator-activated receptor delta, nuclear hormone receptor 1, nuclear receptor subfamily 1 group C member 2, peroxisome proliferator-activated nuclear receptor beta/delta variant 2, peroxisome proliferator-activated receptor beta, peroxisome proliferator-activated receptor delta, peroxisome proliferator-activated receptor delta, peroxisome proliferator-activated receptor delta isoform 4 |
| Gene name: |
PPARD, PPARD |
| Gene synonims: |
FAAR, NR1C2, NR1C2, NUC1, NUC1, NUCI, NUCII, PPAR-beta, PPAR-delta, PPARB, PPARB, PPARD, PPARD |
| Category: |
Antibodies |
| Clonality: |
Polyclonal Antibodies |
| Clone: |
Not applicable to Polyclonal Antibodies |
| Reacts with: |
Mouse (Mus musculus), Rat (Rattus norvegicus), Human (Homo sapiens) |
| Specificity: |
PPARD, This is an antibody designed to detect PPARD |
| Purification method: |
This antibody was purified via antigen affinity purification method |
| Concentration: |
1, 1mg/mL |
| Storage, shipping and handling: |
Avoid cycles of freezing and thawing as they may denaturate the polypeptide chains of the antibody, Due to transportation or handling reasons, For longer periods of time we recommend keeping the vial frozen at -40 or -80, Upon receving, We recommend you to briefly cetrifuge the vial prior to use to gather the content on the bottom, freeze at -20, small amounts of the antibody might get caught on the lid or walls of the vial, The antibody is shipped at +4 degrees Celsius |
| Applications: |
EIA, ELI-Spot, IFA, Western Blot (WB), ELISA |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals they should be stored frozen at - 24° |
| Gene target: |
PPARD |
| Short name: |
Anti- PPARD Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
Antibody to peroxisome proliferator-activated receptor delta (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
DNA-templated and biological process this GO :0006357 and regulation of transcription from RNA polymerase II promoter and biological process this GO :0006367 and transcription initiation from RNA polymerase II promoter and biological process this GO :0006629 and lipid metabolic process and biological process this GO :0006635 and fatty acid beta-oxidation and biological process this GO :0006776 and vitamin A metabolic process and biological process this GO :0007507 and heart development and biological process this GO :0007566 and embryo implantation and biological process this GO :0008144 and drug binding and molecular function this GO :0008203 and cholesterol metabolic process and biological process this GO :0008270 and zinc ion binding and molecular function this GO :0008283 and cell proliferation and biological process this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0008289 and lipid binding and molecular function this GO :0008366 and axon ensheathment and biological process this GO :0008654 and phospholipid biosynthetic process and biological process this GO :0009062 and fatty acid catabolic process and biological process this GO :0009299 and mRNA transcription and biological process this GO :0009749 and response to glucose and biological process this GO :0010033 and response to organic substance and biological process this GO :0010467 and gene expression and biological process this GO :0014068 and positive regulation of phosphatidylinositol 3-kinase signaling and biological process this GO :0014823 and response to activity and biological process this GO :0014912 and negative regulation of smooth muscle cell migration and biological process this GO :0015758 and glucose transport and biological process this GO :0015908 and fatty acid transport and biological process this GO :0019395 and fatty acid oxidation and biological process this GO :0030154 and cell differentiation and biological process this GO :0030308 and negative regulation of cell growth and biological process this GO :0030522 and intracellular receptor signaling pathway and biological process this GO :0031589 and cell-substrate adhesion and biological process this GO :0032024 and positive regulation of insulin secretion and biological process this GO :0032966 and negative regulation of collagen biosynthetic process and biological process this GO :0033189 and response to vitamin A and biological process this GO :0042060 and wound healing and biological process this GO :0042127 and regulation of cell proliferation and biological process this GO :0042640 and anagen and biological process this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043401 and steroid hormone mediated signaling pathway and biological process this GO :0043565 and sequence-specific DNA binding and molecular function this GO :0043616 and keratinocyte proliferation and biological process this GO :0045598 and regulation of fat cell differentiation and biological process this GO :0045600 and positive regulation of fat cell differentiation and biological process this GO :0045684 and positive regulation of epidermis development and biological process this GO :0045892 and negative regulation of transcription, DNA-templated and biological process this GO :0045893 and positive regulation of transcription, DNA-templated and biological process this GO :0045909 and positive regulation of vasodilation and biological process this GO :0046697 and decidualization and biological process this GO :0048662 and negative regulation of smooth muscle cell proliferation and biological process this GO :0050680 and negative regulation of epithelial cell proliferation and biological process this GO :0050728 and negative regulation of inflammatory response and biological process this GO :0051059 and NF-kappaB binding and molecular function this GO :0051546 and keratinocyte migration and biological process this GO :0060612 and adipose tissue development and biological process this GO :0070539 and linoleic acid binding and molecular function this GO :0071456 and cellular response to hypoxia and biological process this GO :0097190 and apoptotic signaling pathway and biological process, FAAR and NR1C2 and NUC1 and NUCI and NUCII and PPARB, PPARD and IDBG-629858 and ENSBTAG00000017542 and 353106, PPARD and IDBG-83938 and ENSG00000112033 and 5467, Ppard and IDBG-158082 and ENSMUSG00000002250 and 19015, linoleic acid binding, nuclei, this GO :0000122 and negative regulation of transcription from RNA polymerase II promoter and biological process this GO :0001890 and placenta development and biological process this GO :0003677 and DNA binding and molecular function this GO :0003700 and sequence-specific DNA binding transcription factor activity and molecular function this GO :0003707 and steroid hormone receptor activity and molecular function this GO :0003713 and transcription coactivator activity and molecular function this GO :0004879 and ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity and molecular function this GO :0005504 and fatty acid binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005654 and nucleoplasm and cellular component this GO :0006006 and glucose metabolic process and biological process this GO :0006029 and proteoglycan metabolic process and biological process this GO :0006091 and generation of precursor metabolites and energy and biological process this GO :0006355 and regulation of transcription, this GO :0003677 : DNA binding, this GO :0003677 : DNA binding and also this GO :0003700 : sequence-specific DNA binding transcription factor activity and also this GO :0003707 : steroid hormone receptor activity and also this GO :0003713 : transcription coactivator activity and also this GO :0004879 : ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity and also this GO :0005504 : fatty acid binding and also this GO :0005515 : protein binding and also this GO :0008144 : drug binding and also this GO :0008270 : zinc ion binding and also this GO :0008289 : lipid binding and also this GO :0043565 : sequence-specific DNA binding and also this GO :0051059 : NF-kappaB binding and also this GO :0070539 : linoleic acid binding, this GO :0003700 : sequence-specific DNA binding transcription factor activity, this GO :0003707 : steroid hormone receptor activity, this GO :0003713 : transcription coactivator activity, this GO :0004879 : ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity, this GO :0005504 : fatty acid binding, this GO :0005515 : protein binding, this GO :0008144 : drug binding, this GO :0008270 : zinc ion binding, this GO :0008289 : lipid binding, this GO :0043565 : sequence-specific DNA binding, this GO :0051059 : NF-kappaB binding, this GO :0070539 : linoleic acid binding, peroxisome proliferator-activated receptor delta |
| Identity: |
9235 |
| Gene: |
PPARD |
More about : PPARD |
| Long gene name: |
peroxisome proliferator activated receptor delta |
| Synonyms gene name: |
delta peroxisome proliferator-activated receptor delta , peroxisome proliferative activated receptor |
| Synonyms: |
NUC1 NUCII FAAR NR1C2 |
| Locus: |
6p21, 31 |
| Discovery year: |
1996-03-12 |
| GenBank acession: |
L07592 |
| Entrez gene record: |
5467 |
| Pubmed identfication: |
1333051 |
| RefSeq identity: |
NM_006238 |
| Classification: |
Nuclear hormone receptors |
| Havana BLAST/BLAT: |
OTTHUMG00000014567 |